Research Use Only. Semaglutide is sold as a chemical reagent for in-vitro laboratory research. It is not a drug, supplement, or compounded preparation, and it is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
Wholesale Catalog
Available Doses
Wholesale pricing for Semaglutide is provided by quote based on dose and order volume. Tell us what you need and your account manager will send a personalized quote — typically within 10 minutes during business hours.
Overview
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
History
Research into endocrine peptide biology began in the 1980s with the identification of key peptide roles in signaling pathways. Semaglutide was developed with structural modifications — a C18 fatty diacid chain attached via a linker to lysine at position 26 and substitutions at positions 8 and 34 — to improve albumin binding and extend duration of action.
Key Areas of Research
- Signaling: pathway dynamics, downstream cascades
- Endocrine: target pathway modulation
- Systemic: lipid pathways, signaling markers
References
- Marso S.P. et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. NEJM, 375:1834–1844.
- Knudsen L.B. et al. (2000). Glucagon-like peptide receptor agonists. Diabetes, 49(12):1978–1984.
- Lau J. et al. (2015). Discovery of the once-weekly GLP-1 analog semaglutide. J Med Chem, 58(18):7370–7380.
Research Use Only
All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.
Related Compounds
GLP-1 & Metabolic
Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
View details →GLP-1 & Metabolic
Retatrutide
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
View details →GLP-1 & Metabolic
Cagrilintide
Cagrilintide is a synthetic, long-acting analog of amylin, studied for activation of target receptor pathways and characterization of endocrine and neuroendocrine signaling.
View details →